Nakajima Akira, Ito Yoshihiro, Asano Masatake, Maeno Masao, Iwata Koichi, Mitsui Narihiro, Shimizu Noriyoshi, Cui Xiao-Mei, Shuler Charles F
Department of Orthodontics, Nihon University School of Dentistry, Tokyo, Japan.
Dev Dyn. 2007 Mar;236(3):791-801. doi: 10.1002/dvdy.21090.
The molecular regulation of palatogenesis continues to be an active area of investigation to provide a foundation for understanding the molecular etiology of cleft palate. Transforming growth factor (TGF) -beta type III receptor (TbetaR-III) has been shown to be specifically expressed in the medial edge epithelium at critical stages of palatal shelf adherence during palatogenesis. The aim of this study was to examine TbetaR-III mRNA localization and expression levels in vivo and to determine the requirement for TbetaR-III expression during palatal fusion in vitro. TbetaR-III gene expression was analyzed by in situ hybridization in tissue specimens and real-time reverse transcriptase-polymerase chain reaction using specific cells in the palatal shelf isolated by laser capture microdissection. TbetaR-III was knocked down in embryonic day (E) 13 palatal shelves in organ culture. Palatal shelf organ cultures were treated with small interfering RNA (siRNA) at final concentrations of 300, 400, and 500 nM, respectively. The treatment with siRNA specific for TbetaR-III decreased the amount of protein by approximately 75%. The reduction in TbetaR-III resulted in a delay in the process of palatal fusion compared with control. The protein expression of phospho-Smad2 was decreased in the TbetaR-III siRNA group. In addition, palatal organ cultures treated with TbetaR-III siRNA + rhTGF-beta3 completely fused by 72 hr in vitro. These results support our hypothesis that TbetaR-III has a critical role in the process of palatal fusion.
腭发育的分子调控仍是一个活跃的研究领域,为理解腭裂的分子病因提供基础。转化生长因子(TGF)-βⅢ型受体(TbetaR-III)已被证明在腭发育过程中腭突附着的关键阶段在内侧边缘上皮中特异性表达。本研究的目的是检测TbetaR-III mRNA在体内的定位和表达水平,并确定体外腭融合过程中TbetaR-III表达的需求。通过组织标本原位杂交和使用激光捕获显微切割分离的腭突中的特定细胞进行实时逆转录-聚合酶链反应分析TbetaR-III基因表达。在器官培养中敲低胚胎第13天(E13)腭突中的TbetaR-III。腭突器官培养物分别用终浓度为300、400和500 nM的小干扰RNA(siRNA)处理。用针对TbetaR-III的siRNA处理使蛋白量减少了约75%。与对照组相比,TbetaR-III的减少导致腭融合过程延迟。TbetaR-III siRNA组中磷酸化Smad2的蛋白表达降低。此外,用TbetaR-III siRNA + rhTGF-β3处理的腭器官培养物在体外72小时内完全融合。这些结果支持我们的假设,即TbetaR-III在腭融合过程中起关键作用。